This inventor holds 1 USPTO granted patent. Top assignee: Kao Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hisashi Tsujimura: Innovator in Dementia Diagnosis
Introduction
Hisashi Tsujimura is a notable inventor based in Utsunomiya, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of dementia. His innovative approach has the potential to improve the accuracy of dementia diagnoses, which is crucial for timely intervention and treatment.
Latest Patents
Hisashi Tsujimura holds a patent for an "Examination method for dementia or risk thereof." This patent describes an accurate and minimally invasive method for diagnosing dementia or mild cognitive impairment. The method involves measuring the amount of stereoisomers of proline in a biological sample collected from a subject and comparing the level of D-proline with a reference value. This innovative technique aims to enhance the diagnostic process for dementia, providing a more reliable assessment of cognitive health.
Career Highlights
Tsujimura is associated with Kao Corporation, a company known for its commitment to innovation in various fields, including healthcare. His work at Kao Corporation has allowed him to focus on developing advanced diagnostic methods that can significantly impact patient care. His dedication to research and development has positioned him as a key figure in the medical diagnostics community.
Collaborations
Hisashi Tsujimura has collaborated with notable colleagues, including Masaru Tsuchiya and Hunkyung Kim. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of diagnostic technologies.
Conclusion
Hisashi Tsujimura's contributions to dementia diagnosis through his patented methods exemplify the importance of innovation in healthcare. His work not only enhances diagnostic accuracy but also paves the way for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
